• <b id="fpcmq"></b>
    <p id="fpcmq"><code id="fpcmq"></code></p>

    1. <video id="fpcmq"></video>

    欄目導航

    avigation

    網站首頁>產品展示 > 衍生化/食品/藥品等標準品 > OLchem植物生長素 > olchemim Labelled plant growth regulators Cytokini
    olchemim Labelled plant growth regulators Cytokini

    發布時間:2017-03-30

    訪問次數:909

    公司地址:廣州市天河區天河北路僑林街47號中旅商務大廈東塔20D

    產品價格:來電咨詢

    產品詳情在線留言

    The labelled natural cytokinins can be distinguished in the MS analysis because the m/z values of their mass spectral fragments are displaced by several mass units (m/z > 2 amu). A known quantity of the labelled cytokinin is added to the initial extract, and after purification the molar ratio of natural cytokinin to labelled internal standard is determined by mass spectrometry. The quantitative analysis by MS was first carried out by Thompson et al., Planta, 124: 207, 1975.

    [15N5]ADENINE (15N-Ade) [6-amino[15N5]purine]

    MW 139.10; crystalline; purity > 97% (HPLC)
    R:22, S:22, 36; C5H515N5
     
    ADENINE
    030 02411mg
    030 02422mg
    030 02435mg

    [2H7]N6-BENZYLADENINE (D-BA) [6-[2H7]benzylaminopurine]

    MW 232.29; crystalline; purity > 97% (HPLC)
    R:36/37/38, S:26, 36; CAS: 147028-87-3; C12H42H7N5
    BENZYLADENINE
    030 02211mg
    030 02222mg
    030 02235mg

    [2H7]N6-BENZYLADENOSINE (D-BAR) [6-[2H7]benzylamino-9-β-D-ribofuranosylpurine]

    MW 364.41; crystalline; purity > 97% (HPLC)
    S:26, 36; C17H122H7N5O4
    BENZYLADENOSINE
    030 05511mg
    030 05522mg
    030 05535mg

    [2H7]N6-BENZYLADENINE-9-GLUCOSIDE (D-BA9G) [6-[2H7]benzylamino-9-β-D-glucopyranosylpurine]

    MW 394.44; crystalline; purity > 97% (HPLC)
    R: 36/37/38, S: 26, 36; C18H142H7N5O5
    N6-BENZYLADENINE-9-GLUCOSIDE(D-BA9G)
    030 32811mg
    030 32822mg
    030 32835mg

    [2H7]N6 - BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (D-BAMP) [6-[2H7]benzylamino-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

    MW 506.38; crystalline; purity > 95% (HPLC)
    S:26, 36; C17H112H7N5Na2O7P.H2O
    N6 a€“ BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (D-BAMP)
    030 50011mg
    030 50022mg
    030 50035mg

    [2H3]DIHYDROZEATIN (D-DHZ) [6-[2H3](4-hydroxy-3-methylbutylamino)purine]

    MW 224.28; crystalline; purity > 98% (HPLC)
    S:26, 36; CAS: 175733-30-9; C10H122H3N5O
     DIHYDROZEATIN (D-DHZ)
    030 06011mg
    030 06022mg
    030 06035mg

    [15N-N4]DIHYDROZEATIN (15N-DHZ) [6-[15N-N4](4-hydroxy-3-methylbutylamino)purine]

    MW 225.24; crystalline; purity > 98% (HPLC)
    S:26, 36; C10H12N15N4O
     DIHYDROZEATIN (N-DHZ)
    030 70211mg
    030 70222mg
    030 70235mg

    [2H3]DIHYDROZEATIN RIBOSIDE (D-DHZR)[6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine]

    MW 356.40; crystalline; purity > 97% (HPLC)
    S:26, 36; CAS: 175733-31-0; C15H202H3N5O5
    DIHYDROZEATIN RIBOSIDE (D-DHZR)
    030 06111mg
    030 06122mg
    030 06135mg

    [2H3]DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-DHZMP) [6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl purine-5'-monophosphate disodium monohydrate]

    MW 498.36; crystalline; purity > 95% (HPLC)
    S:26, 36; C15H192H3N5Na2O8P.H2O
    DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-DHZMP)
    030 50111mg
    030 50122mg
    030 50135mg

    [2H3]DIHYDROZEATIN-9-GLUCOSIDE (D-DHZ9G)[6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-glucopyranosylpurine]

    MW 386.43; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H222H3N5O6
    DIHYDROZEATIN-9-GLUCOSIDE (D-DHZ9G)
    030 06311mg
    030 06322mg
    030 06335mg

    [2H7]DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG) [6-[2H7](4-hydroxy-3-methylbytylamino)-O-β-D-glucopyranosylpurine]

    MW 390.45; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H182H7N5O6
    DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG)
    030 06411mg
    030 06422mg
    030 06435mg

    [2H7]DIHYDROZEATIN-O-GLUCOSIDE RIBOSIDE (D-DZROG) [6-[2H7](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]

    MW 522.56; crystalline; purity > 95% (HPLC)
    S:26, 36; C21H262H7N5O10
    DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG)
    030 06511mg
    030 06522mg
    030 06535mg

    [15N-N4]HYPOXANTINE (15N-Hyp) [6-[15N-N4]hydroxypurine]

    MW 140.09; crystalline; purity > 97% (HPLC)
    S:26, 36; C5H415N4O
     HYPOXANTINE (N-Hyp)
    030 59411mg
    030 59422mg
    030 59435mg

    [2H6]N6-ISOPENTENYLADENINE (D-iP) [6-[2H6](3,3-dimethylallylamino)purine]

    MW 209.29; crystalline; purity > 98% (HPLC)
    S:26, 36; CAS: 175733-28-5; C10H72H6N5
    N6-ISOPENTENYLADENINE (D-iP)
    030 01611mg
    030 01622mg
    030 01635mg

    [15N4-N6]-ISOPENTENYLADENINE (15N4-iP) [6-[15N4](3,3-dimethylallylamino)purine]

    MW 207.22; crystalline; purity > 98% (HPLC)
    S:26, 36; C10H1315N4
     
    ISOPENTENYLADENINE (15N4-iP)
    030 73711mg
    030 73722mg
    030 73735mg

    [2H6]N6-ISOPENTENYLADENOSINE (D-iPR) [6-[2H6](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

    MW 341.41; crystalline; purity > 98% (HPLC)
    S:26, 36; CAS: 175733-29-6; C15H152H6N5O4
     
    N6-ISOPENTENYLADENOSINE (D-iPR)
    030 01711mg
    030 01722mg
    030 01735mg

    [15N]N6-ISOPENTENYLADENOSINE (15N-iPR) [6-[15N](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

    MW 336.36; crystalline; purity > 98% (HPLC)
    S:26, 36; C15H21N415NO4 
     
    ISOPENTENYLADENOSINE (15N-iPR)
    030 70311mg
    030 70322mg
    030 70335mg

    [2H6]N6-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE (D-iPMP) [6[2H6]-(3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

    MW 483.37; crystalline; purity > 95% (HPLC)
    S:26, 36; C15H142H6N5Na2O7P.H2O
    N6-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE (D-iPMP)
    030 50411mg
    030 50422mg
    030 50435mg

    [2H6]N6-ISOPENTENYLADENINE-7-GLUCOSIDE(D-iP7G)[6-[2H6] (3,3-dimethylallylamino)-7-β-D-glucopyranosylpurine]

    MW 371.43; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H172H6N5O5
    N6-ISOPENTENYLADENINE-7-GLUCOSIDE (D-iP7G)
    030 50511mg
    030 50522mg
    030 50535mg

    [2H6] N6-ISOPENTENYLADENINE-9-GLUCOSIDE (D-iP9G) [6-[2H6] (3,3-dimethylallylamino)-9-β-D-glucopyranosylpurine]

    MW 371.43; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H172H6N5O5
    N6-ISOPENTENYLADENINE-9-GLUCOSIDE (D-iP9G)
    030 02311mg
    030 02322mg
    030 02335mg

    [2H6]2-METHYLTHIO-N6-ISOPENTENYLADENINE (D-2MeSiP) [2-methylthio-6-[2H6](3,3-dimethylallylamin)purine]

    MW 255.38; crystalline; purity > 95% (HPLC)
    S:26, 36; C10H72H6N5S
    2-METHYLTHIO-N6-ISOPENTENYLADENINE (D-2MeSiP)
    030 50711mg
    030 50722mg
    030 50735mg

    [2H6]2-METHYLTHIO-N6-ISOPENTENYLADENOSINE (D-2MeSiPR) [2-methylthio-6-[2H6](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

    MW 387.50; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H172H6N5O4S
    2-METHYLTHIO-N6-ISOPENTENYLADENOSINE (D-2MeSiPR)
    030 50611mg
    030 50622mg
    030 50635mg

    [15N4]KINETIN(15N-K) [6-furfurylamino[15N4]purine]

    MW 219.19; CRYSTALLINE; purity > 97% (HPLC)
    S:26, 36; C10H9N15N4O
     
    KINETIN (15N-K )
    030 03411mg
    030 03422mg
    030 03435mg

    [15N-N4]meta-METHOXYTOPOLIN (15N-MemT) [6-(3-methoxybenzylamino)[15N4]purine]

    MW 259.25; crystalline; purity > 98% (HPLC)
    S:26, 36; C13H13N15N4O
     METHOXYTOPOLIN (MemT)
    030 05111mg
    030 05122mg
    030 05135mg

    [15N4]meta-TOPOLIN (15N-mT) [6-(3-hydroxybenzylamino)[15N4]purine]

    MW 245.23; CRYSTALLINE; purity >97% (HPLC)
    S:26, 36; C12H11N15N4O
     
    meta-TOPOLIN (mT)
    030 01011mg
    030 01022mg
    030 01035mg

    [15N4]ortho-TOPOLIN (15N-oT) [6-(2-hydroxybenzylamino)[15N4]purine]

    MW 245.23; CRYSTALLINE; purity >98% (HPLC)
    S:26, 36; C12H11N15N4O
     
    ortho-TOPOLIN (oT)
    030 01211mg
    030 01222mg
    030 01235mg

    [15N4]para-TOPOLIN (15N-pT) [6-(4-hydroxybenzylamino)[15N4]purine]

    MW 245.23; CRYSTALLINE; purity >98% (HPLC)
    S:26, 36; C12H11N15N4O
     
    para-TOPOLIN (pT)
    030 04511mg
    030 04522mg
    030 04535mg

    [2H5]trans-ZEATIN (D-tZ)[6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

    MW 224.28; crystalline; purity > 98% (HPLC); cis isomer <5%
    S:26, 36; CAS: 72963-19-0; C10H82H5N5O
     
    trans-ZEATIN (D-tZ)
    030 03011mg
    030 03022mg
    030 03035mg

    [15N]trans-ZEATIN (15N-tZ) [6-((E)-4-hydroxy-3-methylbut-2-enylamino) purine]

    MW 220.24; crystalline; purity > 98% (HPLC)
    S:26, 36; C10H13N415NO
    trans-ZEATIN (15N-tZ)
    030 70411mg
    030 70422mg
    030 70435mg

    [15N4]trans-ZEATIN (15N4-tZ) [6-[15N4]((E)-4-hydroxy-3-methylbut-2-enylamino) purine]

    MW 223.22; crystalline; purity > 98% (HPLC)
    S:26, 36; C10H1315N4NO
    trans-ZEATIN (15N4-tZ)
    030 73811mg
    030 73822mg
    030 73835mg

    [2H5]trans-ZEATIN RIBOSIDE (D-tZR) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

    MW 356.40; crystalline; purity > 97% (HPLC); cis isomer <0.2%
    S:26, 36; CAS: 72963-21-4; C15H162H5N5O5
    trans-ZEATIN RIBOSIDE (D-ZtR)
    030 03111mg
    030 03122mg
    030 03135mg

    [2H5]trans-ZEATIN-7-GLUCOSIDE (D-tZ7G) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-7-β-D-glucopyranosylpurine]

    MW 386.42; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H182H5N5O6
    trans-ZEATIN-7-GLUCOSIDE (D-tZ7G)
    030 51111mg
    030 51122mg
    030 51135mg

    [2H5]trans-ZEATIN-9-GLUCOSIDE (D-tZ9G) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]

    MW 386.42; crystalline; purity > 95% (HPLC)
    S:26, 36; CAS: 84744-92-3; C16H182H5N5O6
    trans-ZEATIN-9-GLUCOSIDE (D-tZ9G)
    030 04711mg
    030 04722mg
    030 04735mg

    [2H5]trans-ZEATIN-O-GLUCOSIDE (D-tZOG) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-O-β-D-glucopyranosylpurine]

    MW 386.42; crystalline; purity > 95% (HPLC)
    S:26, 36; CAS: 72963-23-6; C16H182H5N5O6
    trans-ZEATIN-O-GLUCOSIDE (D-tZOG)
    030 51211mg
    030 51222mg
    030 51235mg

    [2H5]trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (D-tZROG) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]

    MW 518.54; crystalline; purity > 95% (HPLC)
    S:26, 36; CAS: 69700-29-4; C21H262H5N5O10
    trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (D-tZROG)
    030 51311mg
    030 51322mg
    030 51335mg

    [2H5]trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-tZMP) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

    MW 498.29; crystalline; purity > 95% (HPLC)
    S:26, 36; C15H152H5N5Na2O8P.H2O
    trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-ZMP)
    030 51411mg
    030 51422mg
    030 51435mg

    [2H5]2-METHYLTHIO-trans-ZEATIN (D-2MetSZ) [2-methylthio-6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

    MW 270.37; crystalline; purity > 95% (HPLC)
    S:26, 36; C11H102H5N5OS
    2-METHYLTHIO-trans-ZEATIN (D-2MetSZ)
    030 51711mg
    030 51722mg
    030 51735mg

    [2H5]2-METHYLTHIO-trans-ZEATIN RIBOSIDE (D-2MeStZR) [2-methylthio-6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

    MW 402.49; crystalline; purity > 95% (HPLC)
    S:26, 36; C16H182H5N5O5S
    2-METHYLTHIO-trans-ZEATIN RIBOSIDE (D-2MeStZR)
    030 51811mg
    030 51822mg
    030 51835mg

    [15N4]cis-ZEATIN (15N-cZ) [6-[15N4]((Z)-4-hydroxy-3-methylbut-2-enylamino) purine]

    MW 223.22; crystalline; purity > 98% (HPLC)
    S:26, 36; C10H13N15N4O
    cis-ZEATIN (15N-cZ)
    030 03211mg
    030 03222mg
    030 03235mg
    日本VPSWINDOWS18_吴仁惠_精品久久人妻AV中文字幕_精品无码一区二区三区亚洲桃色